MiSAM opposes bill giving $50 million in opioid settlement funds to ibogaine research
Alcoholism & Drug Abuse Weekly June 29, 2026 Peer reviewed DOI: 10.1002/adaw.34965 via OpenAlex
Summary
The Michigan Society of Addiction Medicine (MiSAM) opposes bill HB 6020, which proposes to use opioid settlement funds for expanding research into ibogaine. MiSAM's stance highlights concerns regarding the allocation of these funds and the implications for opioid addiction treatment.
Study at a glance
| Key finding | MiSAM has expressed opposition to using opioid settlement funds for ibogaine research. |
|---|
Abstract
The Michigan Society of Addiction Medicine (MiSAM) has written a letter to the Michigan legislature opposing bill HB 6020, which would use opioid settlement funds to expand research into ibogaine.